ClinicalTrials.gov posts results from montelukast study in smokers with asthma

ClinicalTrials.gov has posted results from a completed Phase 4 study evaluating treatment approaches in smokers with asthma.

By LIVE AGAIN Editorial Desk Published 14 Sept 2026 1 min read

Editorial illustration of medical device and medicine safety review — LIVE AGAIN / AI-generated editorial illustration · AI-generated

ClinicalTrials.gov now lists results from NCT00712335, a completed Phase 4 study titled “The Effects of Montelukast on Smokers With Asthma.”

The registry reports data from 105 enrolled participants across asthma and control groups. The study compared montelukast-based treatment with an inhaled fluticasone–salmeterol combination in the asthma groups; the registry tables include participant flow and clinical outcome measures.

These are registry results rather than a new treatment recommendation. The posted tables should be interpreted in the context of the study design, withdrawals and the absence of an independent clinical assessment in this report.

Research & Studies

ClinicalTrials.gov reports pharmacokinetic results for apremilast study

A completed Phase 1 study in 28 healthy Korean men reports pharmacokinetic measurements for single and repeated doses of apremilast.

14 Sept 20261 min read

Read article

Editorial illustration of kidney transplant research and clinical outcome monitoring

Research & Studies

Registry Results Report Dapagliflozin Findings in Kidney Transplant Recipients

Registry results from the INFINITI study show numerical differences between dapagliflozin and placebo after 12 weeks, but the registry tables provide no comparative p-values or confidence intervals.

8 Sept 20261 min read

Read article